Rise Gold Vs. SpringWorks Therapeutics Industry Stock Comparison

Sell

7

RYES
Rise Gold

Last Price:

$0.06

Seasonality Move:

-14.99%

Sell

15

SWTX
SpringWorks Therapeutics

Last Price:

$36.97

Seasonality Move:

5.59%

Sell

7

Rise Gold (RYES) is a Sell

Is Rise Gold a Buy, Sell or Hold?

The current Rise Gold [RYES] share price is $0.06. The Score for RYES is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
RYES is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

15

SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

The current SpringWorks Therapeutics [SWTX] share price is $36.99. The Score for SWTX is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
SWTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

RYES Stock Price Chart

What is Rise Gold's stock price today?

The Rise Gold share price today is $0.06

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYES is experiencing buying pressure, which is a positive indicator for future bullish movement.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

The SpringWorks Therapeutics share price today is $36.99

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing slight selling pressure.

RYES Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0	Buy
Relative Strength Index (14 RSI):	44.88	Sell
Chaikin Money Flow:	57100	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.05 - 0.09)	Sell
Bollinger Bands (100):	(0.06 - 0.1)	Sell

SWTX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.41	Sell
Relative Strength Index (14 RSI):	31.76	Sell
Chaikin Money Flow:	-1228444	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(43.93 - 51.91)	Sell
Bollinger Bands (100):	(35.17 - 50.17)	Sell

RYES Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.08	Sell
20-day SMA:	0.07	Sell
50-day SMA:	0.07	Sell
200-day SMA:	0.11	Sell
8-day EMA:	0.08	Sell
20-day EMA:	0.07	Sell
50-day EMA:	0.07	Sell
200-day EMA:	0.1	Sell

SWTX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	43.32	Sell
20-day SMA:	47.1	Sell
50-day SMA:	47.64	Sell
200-day SMA:	39.14	Sell
8-day EMA:	42.51	Sell
20-day EMA:	45.83	Sell
50-day EMA:	46.19	Sell
200-day EMA:	41.19	Sell

Rise Gold Earnings Growth & RYES Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.

Rise Gold Technical Analysis

	Mar 25	Mar 26	Mar 27	Mar 28	Mar 31	Apr 1	Apr 2	Apr 3	Apr 4	Apr 7
	Mar						Apr
	25	26	27	28	31	01	02	03	04	07
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SpringWorks Therapeutics Technical Analysis

	Mar 25	Mar 26	Mar 27	Mar 28	Mar 31	Apr 1	Apr 2	Apr 3	Apr 4	Apr 7
	Mar						Apr
	25	26	27	28	31	01	02	03	04	07
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):